bpc 157 fda warning october 2025 People are turning themselves into lab rats': the injectable peptides craze sweeping the US | Well actually BPC 157 Banned: Key Facts

We explained that our proposal to adjust an ACO's historical benchmark to exclude Medicare Parts A and B FFS payment amounts associated with the HCPCS or CPT codes displaying SAHS billing activity during a performance year would achieve greater consistency between the benchmark period and the performance year, given that we are excluding all payments on specified claim types for the selected codes from performance year calculations, including payments that would have been made in the absence of any SAHS billing activity

No clinical or therapeutic outcomes are implied

However, this amount can increase for those with B12 absorption issues, pregnant or breastfeeding women, and others with increased physiological needs

Sterility and preparation accuracy are critical in any peptide handling

S., & McCann, S